Clinical Trials Directory

Trials / Unknown

UnknownNCT00970398

Effect of an Infant Formula on Infant Growth, Health and Immune Functions

Effect of Infant Formula With Bovine Milk Osteopontin on Infant Growth, Health and Immune functions-a Double-blind Randomized Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
320 (estimated)
Sponsor
Biostime, Inc. · Industry
Sex
All
Age
1 Day – 30 Days
Healthy volunteers
Accepted

Summary

The specific objectives of this study are to evaluate the effects of bovine milk osteopontin added to infant formula on infant growth, health and immune functions.

Detailed description

Breast-fed infants will be used as a reference group and formula-fed infants will be fed control formula or the same formula supplemented with Osteopontin at a concentration 50% or 100% of that of breast milk. The hypothesis is that supplementation of bovine milk Osteopontin in infant formula will have positive effects on infant growth, health and immune functions.

Conditions

Interventions

TypeNameDescription
OTHERInfant formula supplemented with bovine milk OsteopontinInfant formula supplemented with bovine milk osteopontin at 50% and 100% levels of that of breast milk respectively.
OTHERStandard infant formulaInfant formula without supplementation of bovine milk Osteopontin

Timeline

Start date
2009-09-01
Primary completion
2012-09-01
Completion
2013-07-01
First posted
2009-09-02
Last updated
2013-04-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00970398. Inclusion in this directory is not an endorsement.